Agenus Inc.

URI: https://gptkb.org/entity/Agenus_Inc.

GPTKB entity

Predicate	Object
gptkbp:instance_of	gptkb:biotechnology
gptkbp:acquired	gptkb:4_D_Pharma Checkpoint Therapeutics
gptkbp:ceo	gptkb:Garo_H._Armen
gptkbp:clinical_trial	multiple cancer therapies
gptkbp:employees	over 200
gptkbp:focus	immuno-oncology
gptkbp:founded	gptkb:1994
gptkbp:founder	gptkb:Garo_H._Armen
gptkbp:headquarters	gptkb:Lexington,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label	Agenus Inc.
gptkbp:partnership	gptkb:Celyad gptkb:Eli_Lilly gptkb:GSK gptkb:Zymeworks gptkb:Kite_Pharma gptkb:Merck_KGa_A gptkb:Astra_Zeneca gptkb:Sanofi gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Janssen_Pharmaceuticals gptkb:Pfizer gptkb:Apexigen gptkb:Merck_&_Co. gptkb:Roche gptkb:Bayer gptkb:Amgen gptkb:Blueprint_Medicines gptkb:Sorrento_Therapeutics gptkb:Abb_Vie gptkb:Celgene gptkb:Adaptimmune gptkb:Immuno_Gen gptkb:Incyte gptkb:Onco_Sec_Medical gptkb:Regeneron gptkb:Cure_Vac gptkb:Novartis gptkb:Nant_Kwest gptkb:TCR2_Therapeutics gptkb:Takeda
gptkbp:product	gptkb:Agen_T-Cell gptkb:Agen_T-Cell-001 Agen T-Cell-002 Agen T-Cell-003 Agen T-Cell-004 Agen T-Cell-005 Agen T-Cell-006 Agen T-Cell-007 Agen T-Cell-008 Agen T-Cell-009 Agen T-Cell-010
gptkbp:research_focus	immune checkpoint inhibitors
gptkbp:revenue	$50 million (2020)
gptkbp:stock_symbol	AGEN
gptkbp:traded_on	gptkb:NASDAQ
gptkbp:type	gptkb:public_company
gptkbp:website	www.agenusbio.com
gptkbp:bfsParent	gptkb:Roche_Diagnostics
gptkbp:bfsLayer	4